Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement 2023-11-17 16:00
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange 2023-11-17 14:00
Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day 2023-11-17 08:00
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial 2023-11-16 22:00
TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating Next-Generation TB Drug 2023-11-16 20:20
ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing 2023-11-16 20:08
Henlius Reported Financial Results for the First Three Quarters of 2023: Total Revenue Exceeded RMB3.9 billion, Profitability Further Improved 2023-11-15 20:16
RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology 2023-11-15 16:35
"Read Medicine Labels" - How to Safely Use Green Chiretta Against COVID-19 2023-11-15 14:58
Riding the tide, realize the future: The BD paths for Chinese Biotech 2023-11-15 10:42
Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target 2023-11-14 21:30
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference 2023-11-14 20:47
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO 2023-11-14 08:27
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023 2023-11-14 06:40
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023 2023-11-14 06:40
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam® 2023-11-14 06:33
Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety 2023-11-14 03:00
SCG Cell Therapy Announces Late-Breaking Clinical Data at AASLD Showing SCG101 Improved Tumor Reponses and Achieved Sustained Antiviral Activates in Patients with Advanced HBV-related Hepatocellular Carcinoma 2023-11-14 02:00
OliPass Discloses Painful but Hilarious Clinical Findings from a Phase 2a Trial in OA Patients with Nav1.7 Selective Inhibitor OLP-1002 2023-11-13 22:00
PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE 2023-11-13 21:00
1 66 67 68 69 70 413